1. Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness;Johnsen E;Ther Adv Chronic Dis,2012
2. Lumateperone tosylate, a selective and concurrent modulator of serotonin, dopamine, and glutamate, in the treatment of schizophrenia;Maini K;Health Psychol Res,2021
3. FDA Approves Intra-Cellular Therapies’ Novel Antipsychotic, CAPLYTA® (lumateperone) for the Treatment of Schizophrenia in Adults. (2019). https.//www.globenewswire.com/news-release/2019/12/23/1963993/0/en/FDA-Approves-Intra-Cellular-Therapies-Novel-Antips....
4. Lumateperone: first approval;Blair HA;Drugs,2020
5. Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression in Adults. (2021). https.//ir.intracellulartherapies.com/news-releases/news-release-details/intra-cellular-therapies-announces-us-fda-ap....